Egypt’s MOHP partners with Altibbi on the national Blood Plasma Project

Egypt’s MOHP partners with Altibbi on the national Blood Plasma Project

Altibbi, digital health platform, announces a new partnership with Egypt’s Ministry of Health and Population, on the Blood Plasma Project to collect blood plasma and manufacture its derivatives.

Egypt’s Ministry of Health and Population has announced a national project to establish blood plasma donations for medicine production. The project is part of President Abdel Fattah Al-Sisi’s initiative to achieve self-sufficiency in plasma derivatives. The availability of plasma derivatives will contribute to the production of necessary medicines and help to treat various pathological conditions, including kidney, liver, blood and chronic diseases, and treat burns. 

Altibbi Egypt will provide free, unlimited medical consultations for all plasma donors for one full year to encourage Egyptian citizens to donate plasma.

“There is a great synergy between Altibbi Egypt and the Ministry to integrate technology into healthcare to raise service levels and make it easy for recipients and providers. Egypt is one of Altibbi’s key markets and we’re delighted to continue our work there, following our 1130 hotline launch in December. This partnership is a major step for Altibbi in delivering quality healthcare services for all in the region,” Abdellatif Olama, Chief Growth Officer at Altibbi, said.

Altibbi will also publish promotional information on its platform to encourage users to donate plasma at the centers to be announced by the Ministry of Health and Population.

Founded in 2011, Altibbi has over two million pages of content, 24/7 Telehealth service in seven Arab countries and +500,000 daily users. In 2020, the Company was able to deliver healthcare services to over 300 million patients worldwide, expanded its services to 12 countries and created job opportunities for 60,000 doctors around the region.

If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.